Implementing the Global Plan to Stop TB, 2011-2015-Optimizing Allocations and the Global Fund's Contribution: A Scenario Projections Study

In: Korenromp , E , Glaziou , P , Fitzpatrick , C , Floyd , K , Hosseini , M , Raviglione , M , Atun , R & Williams , B 2012 , ' Implementing the Global Plan to Stop TB, 2011-2015-Optimizing Allocations and the Global Fund's Contribution: A Scenario Projections Study ' , PLoS One (print) , vol. 7 , no. 6 . https://doi.org/10.1371/journal.pone.0038816

Abstract

Background: The Global Plan to Stop TB estimates funding required in low- and middle-income countries to achieve TB control targets set by the Stop TB Partnership within the context of the Millennium Development Goals. We estimate the contribution and impact of Global Fund investments under various scenarios of allocations across interventions and regions. Methodology/Principal Findings: Using Global Plan assumptions on expected cases and mortality, we estimate treatment costs and mortality impact for diagnosis and treatment for drug-sensitive and multidrug-resistant TB (MDR-TB), including antiretroviral treatment (ART) during DOTS for HIV-co-infected patients, for four country groups, overall and for the Global Fund investments. In 2015, China and India account for 24% of funding need, Eastern Europe and Central Asia (EECA) for 33%, sub-Saharan A Conclusions/Significance: These findings, alongside country funding gaps, domestic funding and implementation capacity and equity considerations, should inform strategies and policies for international donors, national governments and disease control programs to implement a more optimal investment approach focusing on highest-impact populations and interventions.